Robert Paul - 09 Aug 2021 Form 4 Insider Report for Alector, Inc. (ALEC)

Role
Chief Medical Officer
Signature
/s/ David Oh, attorney-in-fact
Issuer symbol
ALEC
Transactions as of
09 Aug 2021
Net transactions value
-$378,522
Form type
4
Filing time
11 Aug 2021, 18:23:30 UTC
Previous filing
08 Jul 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALEC Common Stock Options Exercise $79,079 +9,691 +4.1% $8.16 244,010 09 Aug 2021 Direct
transaction ALEC Common Stock Options Exercise $88,563 +8,734 +3.6% $10.14 252,744 09 Aug 2021 Direct
transaction ALEC Common Stock Options Exercise $77,604 +4,525 +1.8% $17.15 257,269 09 Aug 2021 Direct
transaction ALEC Common Stock Sale $615,430 -22,650 -8.8% $27.17 234,619 09 Aug 2021 Direct F1, F2
transaction ALEC Common Stock Sale $8,337 -300 -0.13% $27.79 234,319 09 Aug 2021 Direct F1, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALEC Employee Stock Option (right to buy) Options Exercise $0 -9,691 -11% $0.000000 81,000 09 Aug 2021 Common Stock 9,691 $8.16 Direct F4
transaction ALEC Employee Stock Option (right to buy) Options Exercise $0 -8,734 -22% $0.000000 31,250 09 Aug 2021 Common Stock 8,734 $10.14 Direct F5
transaction ALEC Employee Stock Option (right to buy) Options Exercise $0 -4,525 -5.1% $0.000000 84,450 09 Aug 2021 Common Stock 4,525 $17.15 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported by the reporting person were effected pursuant to a Rule 10b5-1 trading plan adopted on May 28, 2020.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.71 to $27.67, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.71 to $27.83, inclusive.
F4 Shares subject to the option vest in 48 equal monthly installments beginning on August 2, 2018.
F5 One-fourth of the total number of shares subject to the option grant vested on November 1, 2019, and an additional 1/48th of the shares subject vest monthly thereafter.
F6 Shares subject to the option vest in 48 equal monthly installments beginning on December 6, 2019.